Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
“Cgrp Antibodies”
Abstract: The present invention provides human engineered calcitonin gene related peptide (CGRP) antibodies or antigen-binding fragment thereof. In addition the present invention provides the use of the human engineered calcitonin gene related peptide (CGRP) antibodies or antigen-binding fragment thereof for the treatment of osteoarthritis pain.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
23 October 2012
Publication Number
51/2014
Publication Type
INA
Invention Field
BIO-CHEMISTRY
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2019-01-17
Renewal Date
Applicants
ELI LILLY AND COMPANY
Lilly Corporate Center City of Indianapolis State of Indiana United States of America
Inventors
1. Barrett ALLAN
c/o Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 United States of America
2. Robert Jan BENSCHOP
c/o Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 United States of America
3. Mark Geoffrey CHAMBERS
c/o Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 United States of America
4. Ryan James DARLING
c/o Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 United States of America
Specification
PLEASE SEE THE SPECIFICATION ATTACHED
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 9083-CHENP-2012 FORM-18 26-10-2012..pdf | 2012-10-26 |
| 2 | 9083-CHENP-2012 POWER OF ATTORNEY 26-10-2012..pdf | 2012-10-26 |
| 3 | 9083-CHENP-2012 CORRESPONDENCE OTHERS 26-10-2012.pdf | 2012-10-26 |
| 4 | 9083-CHENP-2012 CORRESPONDENCE OTHERS 26-10-2012..pdf | 2012-10-26 |
| 7 | Form-1.pdf | 2012-10-29 |
| 8 | 9083-CHENP-2012 CORRESPONDENCE OTHERS 03-12-2012.pdf | 2012-12-03 |
| 9 | 9083-CHENP-2012 CORRESPONDENCE OTHERS 28-01-2013.pdf | 2013-01-28 |
| 10 | 9083-CHENP-2012 FORM-3 19-04-2013.pdf | 2013-04-19 |
| 11 | 9083-CHENP-2012 CORRESPONDENCE OTHERS 19-04-2013.pdf | 2013-04-19 |
| 12 | FORM-2.pdf | 2014-11-26 |
| 13 | ABSTRACT.pdf | 2014-11-26 |
| 14 | 9083-CHENP-2012 FORM-13 01-05-2015.pdf | 2015-05-01 |
| 15 | IP 21893 (Form 13).pdf | 2015-05-05 |
| 16 | IP 21893 (Form 1).pdf | 2015-05-05 |
| 17 | 9083-CHENP-2012-FER.pdf | 2017-10-26 |
| 18 | 9083-CHENP-2012-FORM-26 [08-03-2018(online)].pdf | 2018-03-08 |
| 19 | Correspondence by Agent_General Power of Attorney_09-03-2018.pdf | 2018-03-09 |
| 20 | 9083-CHENP-2012-OTHERS [15-03-2018(online)].pdf | 2018-03-15 |
| 21 | 9083-CHENP-2012-FER_SER_REPLY [15-03-2018(online)].pdf | 2018-03-15 |
| 22 | 9083-CHENP-2012-CORRESPONDENCE [15-03-2018(online)].pdf | 2018-03-15 |
| 23 | 9083-CHENP-2012-CLAIMS [15-03-2018(online)].pdf | 2018-03-15 |
| 24 | 9083-CHENP-2012-ABSTRACT [15-03-2018(online)].pdf | 2018-03-15 |
| 25 | 9083-CHENP-2012-FORM 3 [21-03-2018(online)].pdf | 2018-03-21 |
| 26 | 9083-CHENP-2012-HearingNoticeLetter.pdf | 2018-10-25 |
| 27 | 9083-CHENP-2012-Correspondence to notify the Controller (Mandatory) [26-11-2018(online)].pdf | 2018-11-26 |
| 28 | 9083-CHENP-2012-ExtendedHearingNoticeLetter_19Dec2018.pdf | 2018-12-01 |
| 29 | 9083-CHENP-2012-Correspondence to notify the Controller (Mandatory) [18-12-2018(online)].pdf | 2018-12-18 |
| 30 | 9083-CHENP-2012-Written submissions and relevant documents (MANDATORY) [02-01-2019(online)].pdf | 2019-01-02 |
| 31 | Marked up Claims_Granted 305835_17-01-2019.pdf | 2019-01-17 |
| 32 | Description_Granted 305835_17-01-2019.pdf | 2019-01-17 |
| 33 | Claims_Granted 305835_17-01-2019.pdf | 2019-01-17 |
| 34 | Abstract_Granted 305835_17-01-2019.pdf | 2019-01-17 |
| 35 | 9083-CHENP-2012-PatentCertificate17-01-2019.pdf | 2019-01-17 |
| 36 | 9083-CHENP-2012-IntimationOfGrant17-01-2019.pdf | 2019-01-17 |
| 37 | 9083-CHENP-2012-RELEVANT DOCUMENTS [13-02-2020(online)].pdf | 2020-02-13 |
| 38 | 9083-CHENP-2012-PETITION UNDER RULE 137 [01-12-2022(online)].pdf | 2022-12-01 |
Search Strategy
| 1 | strategy_9083_26-10-2017.pdf |